Clinical Trial Update: Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and adherence of a vaginal ring with dapivirine plus oral emtricitabine/tenofovir disoproxil fumarate in adolescent and young adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Dapivirine vaginal ring (dapivirine)
• Emtricitabine/Tenofovir disoproxil fumarate (emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2023-02-03